Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/103872
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort
Author: Eggers, S.
Sadedin, S.
van den Bergen, J.
Robevska, G.
Ohnesorg, T.
Hewitt, J.
Lambeth, L.
Bouty, A.
Knarston, I.
Tan, T.
Cameron, F.
Werther, G.
Hutson, J.
O'Connell, M.
Grover, S.
Heloury, Y.
Zacharin, M.
Bergman, P.
Kimber, C.
Brown, J.
et al.
Citation: Genome Biology, 2016; 17(1):243-1-243-21
Publisher: Biomed Central
Issue Date: 2016
ISSN: 1474-7596
1474-760X
Statement of
Responsibility: 
Stephanie Eggers ... Elizabeth M. Thompson, Jennifer Couper, Anne Baxendale, Jozef Gecz ... et al.
Abstract: BACKGROUND: Disorders of sex development (DSD) are congenital conditions in which chromosomal, gonadal, or phenotypic sex is atypical. Clinical management of DSD is often difficult and currently only 13% of patients receive an accurate clinical genetic diagnosis. To address this we have developed a massively parallel sequencing targeted DSD gene panel which allows us to sequence all 64 known diagnostic DSD genes and candidate genes simultaneously. RESULTS: We analyzed DNA from the largest reported international cohort of patients with DSD (278 patients with 46,XY DSD and 48 with 46,XX DSD). Our targeted gene panel compares favorably with other sequencing platforms. We found a total of 28 diagnostic genes that are implicated in DSD, highlighting the genetic spectrum of this disorder. Sequencing revealed 93 previously unreported DSD gene variants. Overall, we identified a likely genetic diagnosis in 43% of patients with 46,XY DSD. In patients with 46,XY disorders of androgen synthesis and action the genetic diagnosis rate reached 60%. Surprisingly, little difference in diagnostic rate was observed between singletons and trios. In many cases our findings are informative as to the likely cause of the DSD, which will facilitate clinical management. CONCLUSIONS: Our massively parallel sequencing targeted DSD gene panel represents an economical means of improving the genetic diagnostic capability for patients affected by DSD. Implementation of this panel in a large cohort of patients has expanded our understanding of the underlying genetic etiology of DSD. The inclusion of research candidate genes also provides an invaluable resource for future identification of novel genes.
Keywords: Disorders of sex development; gonad; testis; ovaries; ovotestes; massively parallel sequencing; MPS; cohort; targeted gene panel; genetic diagnosis; variant; mutation
Rights: © The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
RMID: 0030059424
DOI: 10.1186/s13059-016-1105-y
Grant ID: http://purl.org/au-research/grants/nhmrc/546517
Appears in Collections:Paediatrics publications

Files in This Item:
File Description SizeFormat 
hdl_103872.pdfPublished version1.96 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.